autologous IL-2-expressing B-CLL vaccine
Term · Oncology and biomedicine · MLC-T-ONC-011665
A cancer vaccine consisting of autologous, B-chronic lymphocytic leukemia (B-CLL) cells harvested from a patient and transduced ex vivo with an adenoviral vector encoding the gene for the human cytokine interleukin-2 (IL-2), with potential immunostimulating and antineoplastic activities. Upon reintroduction into the patient, the autologous IL-2-expressing B-CLL vaccine expresses IL-2, stimulates natural killer (NK) cells, and may enhance the cytotoxic T-lymphocyte (CTL) immune response against the patient's B-CLL cells.
| Identifier | MLC-T-ONC-011665 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous IL2-transduced CLL B cell vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011665",
"term": "autologous IL-2-expressing B-CLL vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine consisting of autologous, B-chronic lymphocytic leukemia (B-CLL) cells harvested from a patient and transduced ex vivo with an adenoviral vector encoding the gene for the human cytokine interleukin-2 (IL-2), with potential immunostimulating and antineoplastic activities. Upon reintroduction into the patient, the autologous IL-2-expressing B-CLL vaccine expresses IL-2, stimulates natural killer (NK) cells, and may enhance the cytotoxic T-lymphocyte (CTL) immune response against the patient's B-CLL cells.",
"synonyms": [
"autologous IL2-transduced CLL B cell vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-il-2-expressing-b-cll-vaccine/"
}
Record 3,000 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.